{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Minretumomab",
  "nciThesaurus": {
    "casRegistry": "195189-17-4",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "A second-generation murine monoclonal antibody based on the antibody B72.3 that is directed against tumor-associated glycoprotein 72 (TAG72).  TAG72 is expressed by gastric, breast, pancreatic, colorectal, and ovarian carcinoma cells.",
    "fdaUniiCode": "235435CH6L",
    "identifier": "C2567",
    "preferredName": "Minretumomab",
    "semanticType": "Amino Acid, Peptide, or Protein",
    "subclassOf": [
      "C129822",
      "C20401"
    ],
    "synonyms": [
      "Antibody CC49, Monoclonal",
      "CC-49",
      "CC-49 Monoclonal Antibody",
      "MAb CC49",
      "MINRETUMOMAB",
      "MOAB CC-49/TAG72 (DW)",
      "Minretumomab",
      "MoAb CC49",
      "Monoclonal Antibody CC-49",
      "Monoclonal Antibody CC49"
    ]
  }
}